tradingkey.logo
tradingkey.logo
Buscar

Helius Medical Technologies Inc

HSDT
Añadir a la lista de seguimiento
1.790USD
+0.050+2.87%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
98.38MCap. mercado
0.00P/E TTM

Más Datos de Helius Medical Technologies Inc Compañía

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

Información de Helius Medical Technologies Inc

Símbolo de cotizaciónHSDT
Nombre de la empresaSolana Co
Fecha de salida a bolsaJun 27, 2014
Director ejecutivoAndreeff (Dane C)
Número de empleados21
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 27
Dirección642 Newtown Yardley Road
CiudadNEWTOWN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal18940
Teléfono12159446100
Sitio Webhttps://heliusmedical.com/
Símbolo de cotizaciónHSDT
Fecha de salida a bolsaJun 27, 2014
Director ejecutivoAndreeff (Dane C)

Ejecutivos de Helius Medical Technologies Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
8.00K
+79.53%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
1.64K
-33.29%
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Joseph Chee
Dr. Joseph Chee
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Cosmo Jiang
Mr. Cosmo Jiang
Director
Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
8.00K
+79.53%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
1.64K
-33.29%
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Helius Medical Technologies Inc?

Los cinco principales accionistas de Helius Medical Technologies Inc son: Mr. Blane Walter

¿Cuántas instituciones poseen acciones de Helius Medical Technologies Inc (HSDT)?

A fecha de 2026Q1, 61 instituciones poseen acciones de Helius Medical Technologies Inc, con un valor de mercado combinado de aproximadamente 16.40M, lo que representa el 28.25% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 1284175.00.